Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Regular session
$27.77
−$0.03 · -0.11%
Regular session · ET · Market data may be delayed.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Day range
Current $27.77
52-week range
Current $27.77
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
85
Deep Value
Sentiment
50
Mixed
Risk
30
Moderate Risk
Momentum
92
Strong Up
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Day range
Current $27.77
52-week range
Current $27.77
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 73.78M USD | 64M USD | 54.72M USD | 48.07M USD | 41.66M USD |
| Cost of goods sold | 15.83M USD | 14.03M USD | 12.99M USD | 11.55M USD | 10.22M USD |
| Gross profit | 57.94M USD | 49.97M USD | 41.73M USD | 36.52M USD | 31.44M USD |
| Research and development | 1.31M USD | 996K USD | 656K USD | 916K USD | 1.36M USD |
| Selling, general, and administrative | 42.75M USD | 39.1M USD | 34.49M USD | 31.6M USD | 27.11M USD |
| Operating expenses | 44.06M USD | 40.1M USD | 35.15M USD | 32.51M USD | 28.47M USD |
| Interest income | 479K USD | 624K USD | 455K USD | 78K USD | 25K USD |
| Depreciation and amortization | 1.08M USD | 1.17M USD | 841K USD | 613K USD | 628K USD |
| Operating income | 13.88M USD | 9.87M USD | 6.58M USD | 4.01M USD | 2.97M USD |
| Net income | 11.3M USD | 7.54M USD | 5.15M USD | 3.17M USD | 2.31M USD |
Company facts updated Oct 9, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
Third-party consensus; not a GoAI recommendation.
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI5.51M0.00%2.3T USD0.03%$381.29+0.46%
iShares Russell 2000 ETFIWM4.85M0.01%77.7B USD0.19%$278.7+0.41%
Vanguard Extended Market ETFVXF2.28M0.00%95.4B USD0.05%$234.61+0.63%
Dimensional - US Small Cap ETFDFAS2.07M0.01%33.8B USD0.31%$78.32+0.28%
iShares Russell 2000 Growth ETFIWO1.74M0.01%14.04B USD0.24%$356.1+0.74%
Fidelity Small-Mid Multifactor ETFFSMD1.45M0.06%2.49B USD0.15%$49.98+0.52%
Vanguard Russell 2000 ETFVTWO1.07M0.01%18B USD0.06%$112.58+0.43%
U.S. Micro Cap Portfolio ETFDFMC839.74K0.01%7.54B USD0.43%$57.795+0.16%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
Dimensional - US Small Cap ETFDFAS
iShares Russell 2000 Growth ETFIWO
Fidelity Small-Mid Multifactor ETFFSMD
Vanguard Russell 2000 ETFVTWO
U.S. Micro Cap Portfolio ETFDFMCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.